India's Cohance Lifesciences hits near 1-1/2-year low on quarterly profit slump
13/11/2025 05:08
** Shares of Cohance Lifesciences COHA.NS slump 9.3% to 625.7 rupees, lowest since June 6, 2024
** Stock logs biggest intraday percentage loss since June 24, 2020
** Pharma co posts 46.5% y/y decline in September-quarter consol net profit; rev from ops drops about 8% y/y
** More than 1.4 mln shares change hands, 4.5x of 30-day avg
** COHA rated "strong buy" by 8 analysts on average; median target price is 1,190 rupees – data compiled by LSEG
** Stock down 45% YTD
(Reporting by Rudra Pratap Singh in Bengaluru)
((rudrapratap.singh@thomsonreuters.com))
Recent news on Cohance Lifesciences
See all newsBrief: Cohance Lifesciences Names Abhimanyu Ojha As CFO
Brief: Cohance Lifesciences Says U.S. FDA Issues Form 483 With Five Observations For Jaggaiahpet Unit In Andhra Pradesh
India's Cohance Lifesciences falls after US FDA inspection at Telangana plant
Brief: Cohance Lifesciences Says Investment Of USD 18 Million In NJ Bio And Aruka Bio
India's Cohance Lifesciences climbs on second-half growth outlook despite Q1 loss